PharmiWeb.com - Global Pharma News & Resources
12-Jul-2019

Amniotic Membrane Market is Anticipated to Surpass USD 5.83 Bn up to 2026

The Global Amniotic Membrane Market Size is anticipated to around USD 5.83 billion by 2026, this market is anticipated to grow with 12.7% CAGR during the forecast time period 2018 to 2026.

Amnion is the innermost coating of the placenta and is used in wound healing primarily due to its pain reduction and bacteriostatic properties. Increasing awareness among the people in the recent past has led to a surge in the number of transplants leading to rising demand for these tissue-based products. It has also led to increase in the number of donations thus, boosting market growth.

Increasing hazardous cases in trauma, burnt cases and leading to cure through surgeries, also increasing awareness highlighting the benefits of amniotic membrane based products are boosting the demand for the products driving the global amniotic membrane market. Increasing cases of cosmetic surgeries performed worldwide is also another factor likely to drive the growth of market during the forecast period. Amniotic membrane is also being utilized in the healing of a large number of ocular surface diseases as it protects surfaces from microbial colonization minimizing the risk of infections.

Numerous NGOs such as American Association of Tissue Banks which regulates tissue donation in the U.S. Presence of similar tissue banks is to ensure zero infection transmission which leads to diseases, which, sequentially, accelerates market growth by increasing the demand. Moreover, a number of medical institutions are trying to bring in novel areas of application for these products by focusing on the research activities in regenerative medicines and applications of stem cell. This is among the other prime factors that are likely to maintain market expansion globally. Cryopreserved amniotic membrane is widely used in hospitals, Ambulatory Surgical Centers (ASCs), and few other specialty clinics. Lyophilization of the tissue post donation conserve the biological and histological activity of the tissue facilitating faster wound recovery.

Download Free Report Sample Pages at https://www.acumenresearchandconsulting.com/request-sample/958

Furthermore, instances and characteristics of growth factors including basic Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Keratinocyte Growth Factor (KGF), Nerve Growth Factor (NGF), Vascular Endothelial Growth Factor (VEGF), and Fibroblast Growth Factor (bFGF), in amniotic membranes encourage wound healing, catalysing its adoption globally. Additionally, its beneficial characteristics, such as anti-inflammatory properties, minimized fibrosis and scar at the site of surgery, reduction in pain, and faster wound healing properties, are also fueling the demand. These products are thus most commonly used in treatment of venous, surgeries, pressure, and ophthalmology, management of chronic wounds, and in the healing of diabetic foot ulcers.

The global amniotic membrane market is segmented into enzyme, application, end-use and region. On the basis of enzyme the global amniotic membrane market is segmented into Cryopreserved Amniotic Membrane, Dehydrated Amniotic Membrane. On the basis of application the global amniotic membrane market is segmented into Surgical Wounds, Ophthalmology, Others. On the basis of the end-user the global amniotic membrane market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research and Academic Institutes. On the basis of region the global amniotic membrane market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East amp; Africa.

Cryopreserved enzyme type is anticipated to be the dominant segment in terms of market share in coming future owing to its effective preservation of biological and histological properties. Surgical wounds application segment is expected to experience higher growth as compared to its other application segments, anticipated to rising usage of these products for surgical applications. Among the end-use segment, specialty clinics are likely to register the greater CAGR during the forecast period attributable to increasing number of reconstructive and cosmetic surgeries being performed globally.

Among the regions, North America amniotic membrane market is a leading having the maximum share owing to presence of a large number of key companies and high incidence of infectious and chronic diseases. This region is expected to continue having the maximum market share during the forecast period. The Asia Pacific amniotic membrane market is anticipated to record the highest CAGR during the forecast period owing to growing population and rising incidence of burn injuries and chronic diseases.

The key players catering to the global amniotic membrane market are Amnio Technology, Alliqua BioMedical Inc.; Applied Biologics LLC; Katena Products, Human Regenerative Technologies DermaSciences; Skye Biologics, Inc. and MiMedx Group Inc. The global players are continuously investing in Ramp;D activities and innovating to have updated product portfolio to attract more and more business opportunity from the emerging nation such as India and China. Further changing customersrsquo; preferences are encouraging global players to develop innovative technology solution to cater best to the market. Also, Increasing Ramp;D investments coupled with technological advancements to commercialise highly efficient products are anticipated to offer lucrative opportunities for industry participants.

View Full Report at https://www.acumenresearchandconsulting.com/amniotic-membrane-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Amniotic Membrane
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Amniotic Membrane Market By Enzyme
1.2.2.1. Global Amniotic Membrane Market Revenue and Growth Rate Comparison By Enzyme (2015-2026)
1.2.2.2. Global Amniotic Membrane Market Revenue Share By Enzyme in 2017
1.2.2.3. Cryopreserved Amniotic Membrane
1.2.2.4. Dehydrated Amniotic Membrane
1.2.2.5. Others
1.2.3. Amniotic Membrane Market By Application
1.2.3.1. Global Amniotic Membrane Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Surgical Wounds
1.2.3.3. Ophthalmology
1.2.3.4. Others
1.2.4. Amniotic Membrane Market By End Users
1.2.4.1. Global Amniotic Membrane Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Ambulatory Surgical Centers (ASCs)
1.2.4.4. Specialty Clinics,
1.2.4.5. Research and Academic Institutes
1.2.4.6. Others
1.2.5. Amniotic Membrane Market by Geography
1.2.5.1. Global Amniotic Membrane Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Amniotic Membrane Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Amniotic Membrane Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Amniotic Membrane Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Amniotic Membrane Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Amniotic Membrane Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Ambulatory Surgical Centers (ASCs) Production Date of Global Amniotic Membrane Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Amniotic Membrane Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Amniotic Membrane Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Amniotic Membrane Major Manufacturers in 2017

CHAPTER 4. AMNIOTIC MEMBRANE MARKET BY ENZYME

4.1. Global Amniotic Membrane Revenue By Enzyme
4.2. Cryopreserved Amniotic Membrane
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Dehydrated Amniotic Membrane
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. AMNIOTIC MEMBRANE MARKET BY APPLICATION

5.1. Global Amniotic Membrane Revenue By Application
5.2. Surgical Wounds
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Ophthalmology
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. AMNIOTIC MEMBRANE MARKET BY END USERS

6.1. Global Amniotic Membrane Revenue By End Users
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Ambulatory Surgical Centers (ASCs)
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Specialty Clinics
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Research and Academic Institutes
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Others
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA AMNIOTIC MEMBRANE MARKET BY COUNTRY

7.1. North America Amniotic Membrane Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Amniotic Membrane Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Amniotic Membrane Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE AMNIOTIC MEMBRANE MARKET BY COUNTRY

8.1. Europe Amniotic Membrane Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Amniotic Membrane Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET BY COUNTRY

9.1. Asia-Pacific Amniotic Membrane Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Amniotic Membrane Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA AMNIOTIC MEMBRANE MARKET BY COUNTRY

10.1. Latin America Amniotic Membrane Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Amniotic Membrane Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST AMNIOTIC MEMBRANE MARKET BY COUNTRY

11.1. Middle East Amniotic Membrane Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Amniotic Membrane Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA AMNIOTIC MEMBRANE MARKET BY COUNTRY

12.1. Africa Amniotic Membrane Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Amniotic Membrane Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Enzyme, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Amnio Technology
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Alliqua BioMedical Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Applied Biologics LLC
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Katena Products
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Human Regenerative Technologies DermaSciences
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Skye Biologics, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. MiMedx Group Inc
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Others
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research

INQUIRY BEFORE BUYING: https://www.acumenresearchandconsulting.com/inquiry-before-buying/958

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/958

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 12-Jul-2019